{"transactions":[{"id":4629031,"issuer":{"id":5442,"kind":"organization","name":"Swarmer, Inc","symbol":"SWMR"},"owners":[{"id":22845,"kind":"person","name":"WAGENHEIM PHILIP","position":1,"cik":"0001405684","reported_name":"WAGENHEIM PHILIP","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-10-02T21:47:23.000Z","date":"2026-10-01","kind":"grant","planned":false,"acquired":true,"shares":6428,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option shall vest in full on the earlier of (i) the one-year anniversary of the grant date and (ii) the Issuer's 2027 Annual Meeting."}],"balance_after":6428,"derivative":{"exercise_price":16.38,"expiration_date":"2036-10-01","underlying":"Common Stock","underlying_shares":6428},"source":{"system":"sec-edgar","filing":"0001104659-26-113391","document":"tm2626938-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2092574/000110465926113391/tm2626938-6_4seq1.xml","form_type":"4"}},{"id":4621862,"issuer":{"id":5442,"kind":"organization","name":"Swarmer, Inc","symbol":"SWMR"},"owners":[{"id":22845,"kind":"person","name":"WAGENHEIM PHILIP","position":1,"cik":"0001405684","reported_name":"WAGENHEIM PHILIP","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrants","published_at":"2026-09-17T21:51:59.000Z","date":"2026-09-16","kind":"other","planned":false,"acquired":false,"shares":899988,"ownership":{"direct":false,"nature":"Theseus Capital Partners, LLC"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"On September 16, 2026, the Reporting Person, through Theseus, exercised in full all 899,988 Common Stock Purchase Warrants (the \"Warrants\") held by Theseus pursuant to the cashless exercise provision contained therein (the \"Warrant Exercise\"). Under the terms of the cashless exercise, no cash consideration was paid to the Issuer. Instead, a portion of the shares of Common Stock otherwise issuable upon exercise of the Warrants was withheld by the Issuer in satisfaction of the aggregate exercise price of $3.3334 per warrant share. Based on a price of $37.2672 per share (the price per share as determined pursuant to the cashless exercise provision of the Warrants), the cashless exercise of all 899,988 Warrants resulted in the issuance to Theseus (or its designee) of 819,487 shares of Common Stock (the \"Warrant Shares\"), after withholding 80,501 shares in payment of the aggregate exercise price. The Warrant Shares are subject to the beneficial ownership limitation of 4.99%"},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"(the \"Beneficial Ownership Limitation\") set forth in the Warrants, and any Warrant Shares in excess of the Beneficial Ownership Limitation are held in abeyance and will not be issued to the Reporting Person until they are able to be received in accordance with the terms of the Warrants (and thus the Reporting Person does not beneficially own shares held in abeyance). Of the Warrant Shares, 768,971 shares were initially issued to Theseus, and the remaining 50,516 shares were held in abeyance. Subsequent to the initial issuance and prior to the date hereof, the remaining 50,516 shares initially held in abeyance were issued to Theseus following an increase in the number of the Issuer's shares outstanding. The foregoing description of the Warrants and the cashless exercise is qualified in its entirety by the terms and conditions of the Warrants, a form of which was filed as Exhibit 4.3 to the Issuer's Registration Statement on Form S-1/A filed with the SEC on February 19, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On September 16, 2026, the Reporting Person, through Theseus, exercised in full all 899,988 Common Stock Purchase Warrants (the \"Warrants\") held by Theseus pursuant to the cashless exercise provision contained therein (the \"Warrant Exercise\"). Under the terms of the cashless exercise, no cash consideration was paid to the Issuer. Instead, a portion of the shares of Common Stock otherwise issuable upon exercise of the Warrants was withheld by the Issuer in satisfaction of the aggregate exercise price of $3.3334 per warrant share. Based on a price of $37.2672 per share (the price per share as determined pursuant to the cashless exercise provision of the Warrants), the cashless exercise of all 899,988 Warrants resulted in the issuance to Theseus (or its designee) of 819,487 shares of Common Stock (the \"Warrant Shares\"), after withholding 80,501 shares in payment of the aggregate exercise price. The Warrant Shares are subject to the beneficial ownership limitation of 4.99%"},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"(the \"Beneficial Ownership Limitation\") set forth in the Warrants, and any Warrant Shares in excess of the Beneficial Ownership Limitation are held in abeyance and will not be issued to the Reporting Person until they are able to be received in accordance with the terms of the Warrants (and thus the Reporting Person does not beneficially own shares held in abeyance). Of the Warrant Shares, 768,971 shares were initially issued to Theseus, and the remaining 50,516 shares were held in abeyance. Subsequent to the initial issuance and prior to the date hereof, the remaining 50,516 shares initially held in abeyance were issued to Theseus following an increase in the number of the Issuer's shares outstanding. The foregoing description of the Warrants and the cashless exercise is qualified in its entirety by the terms and conditions of the Warrants, a form of which was filed as Exhibit 4.3 to the Issuer's Registration Statement on Form S-1/A filed with the SEC on February 19, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The Warrants were immediately exercisable upon the completion of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"The Warrants will expire upon the earlier of (i) 5:00 p.m. Eastern Time on the 5-year anniversary of the effectiveness of the Issuer's registration statement filed in connection with its initial public offering and (ii) 5:00 p.m. Eastern Time on March 22, 2027."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":899988},"source":{"system":"sec-edgar","filing":"0001104659-26-108626","document":"tm2625627-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2092574/000110465926108626/tm2625627-2_4seq1.xml","form_type":"4"}},{"id":4621861,"issuer":{"id":5442,"kind":"organization","name":"Swarmer, Inc","symbol":"SWMR"},"owners":[{"id":22845,"kind":"person","name":"WAGENHEIM PHILIP","position":1,"cik":"0001405684","reported_name":"WAGENHEIM PHILIP","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-09-17T21:51:59.000Z","date":"2026-09-16","kind":"other","planned":false,"acquired":true,"shares":819487,"price":3.3334,"value":2731677.9658,"ownership":{"direct":false,"nature":"Theseus Capital Partners, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"On September 16, 2026, the Reporting Person, through Theseus, exercised in full all 899,988 Common Stock Purchase Warrants (the \"Warrants\") held by Theseus pursuant to the cashless exercise provision contained therein (the \"Warrant Exercise\"). Under the terms of the cashless exercise, no cash consideration was paid to the Issuer. Instead, a portion of the shares of Common Stock otherwise issuable upon exercise of the Warrants was withheld by the Issuer in satisfaction of the aggregate exercise price of $3.3334 per warrant share. Based on a price of $37.2672 per share (the price per share as determined pursuant to the cashless exercise provision of the Warrants), the cashless exercise of all 899,988 Warrants resulted in the issuance to Theseus (or its designee) of 819,487 shares of Common Stock (the \"Warrant Shares\"), after withholding 80,501 shares in payment of the aggregate exercise price. The Warrant Shares are subject to the beneficial ownership limitation of 4.99%"},{"field":"kind","element":"transactionCoding","label":"F4","text":"(the \"Beneficial Ownership Limitation\") set forth in the Warrants, and any Warrant Shares in excess of the Beneficial Ownership Limitation are held in abeyance and will not be issued to the Reporting Person until they are able to be received in accordance with the terms of the Warrants (and thus the Reporting Person does not beneficially own shares held in abeyance). Of the Warrant Shares, 768,971 shares were initially issued to Theseus, and the remaining 50,516 shares were held in abeyance. Subsequent to the initial issuance and prior to the date hereof, the remaining 50,516 shares initially held in abeyance were issued to Theseus following an increase in the number of the Issuer's shares outstanding. The foregoing description of the Warrants and the cashless exercise is qualified in its entirety by the terms and conditions of the Warrants, a form of which was filed as Exhibit 4.3 to the Issuer's Registration Statement on Form S-1/A filed with the SEC on February 19, 2026."},{"field":"kind","element":"transactionCoding","label":"F5","text":"In connection with the Warrant Exercise, the Reporting Person entered into a lock-up agreement with the Issuer (the \"Lock-Up Agreement\") dated as of September 17, 2026, pursuant to which the Reporting Person agreed that all shares of Common Stock received upon exercise of the Warrants (including any shares held in abeyance) are subject to certain transfer restrictions for a six-month period as set forth in the Lock-Up Agreement. The foregoing description of the Lock-Up Agreement is qualified in its entirety by the terms and conditions of the Lock-Up Agreement."}],"balance_after":819487,"source":{"system":"sec-edgar","filing":"0001104659-26-108626","document":"tm2625627-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2092574/000110465926108626/tm2625627-2_4seq1.xml","form_type":"4"}},{"id":4621860,"issuer":{"id":5442,"kind":"organization","name":"Swarmer, Inc","symbol":"SWMR"},"owners":[{"id":22845,"kind":"person","name":"WAGENHEIM PHILIP","position":1,"cik":"0001405684","reported_name":"WAGENHEIM PHILIP","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-09-17T21:51:59.000Z","date":"2026-09-15","kind":"other","planned":false,"acquired":false,"shares":1124981,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Theseus Capital Partners, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pro rata distribution by Theseus Capital Partners, LLC (\"Theseus\"). The Reporting Person is the managing member of Theseus and may be deemed to share voting and dispositive power over the shares held by Theseus."},{"field":"shares","element":"transactionShares","label":"F2","text":"On September 15, 2026, Theseus made a distribution of 1,124,981 shares of common stock to the members of Theseus on a pro rata basis in accordance with the terms of its Operating Agreement. The disposition reflects the Reporting Person's reduction in beneficial ownership resulting from such distribution."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-26-108626","document":"tm2625627-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2092574/000110465926108626/tm2625627-2_4seq1.xml","form_type":"4"}},{"id":685349,"issuer":{"id":5442,"kind":"organization","name":"Swarmer, Inc","symbol":"SWMR"},"owners":[{"id":22845,"kind":"person","name":"WAGENHEIM PHILIP","position":1,"cik":"0001405684","reported_name":"WAGENHEIM PHILIP","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-08-17T20:55:23.000Z","date":"2026-08-13","kind":"grant","planned":false,"acquired":true,"shares":2511,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vested immediately on the grant date."}],"balance_after":2511,"derivative":{"exercise_price":42.99,"expiration_date":"2036-08-13","underlying":"Common Stock","underlying_shares":2511},"source":{"system":"sec-edgar","filing":"0001104659-26-097922","document":"tm2623421-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1405684/000110465926097922/tm2623421-4_4seq1.xml","form_type":"4"}},{"id":739719,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":22845,"kind":"person","name":"WAGENHEIM PHILIP","position":1,"cik":"0001405684","reported_name":"WAGENHEIM PHILIP","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2026-06-12T21:56:21.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":9897,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in four equal quarterly installments, commencing from June 10, 2026 until the one-year anniversary thereafter, occurring on the same day of each succeeding fiscal quarter, subject to the Reporting Person's continuous service with the Company on each respective vesting date."}],"balance_after":9897,"derivative":{"exercise_price":18.16,"expiration_date":"2036-06-09","underlying":"Common Stock","underlying_shares":9897},"source":{"system":"sec-edgar","filing":"0001405684-26-000003","document":"form4-06122026_090615.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000140568426000003/form4-06122026_090615.xml","form_type":"4"}},{"id":830779,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":22845,"kind":"person","name":"WAGENHEIM PHILIP","position":1,"cik":"0001405684","reported_name":"WAGENHEIM PHILIP","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-24T01:23:29.000Z","date":"2026-03-23","kind":"sale","planned":false,"acquired":false,"shares":28200,"price":20.65,"value":582330.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction report was $20.65, and the range of prices were between $20.15 and $20.84, inclusive. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":341147,"source":{"system":"sec-edgar","filing":"0001405684-26-000002","document":"form4-03242026_010325.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000140568426000002/form4-03242026_010325.xml","form_type":"4"}},{"id":830778,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":22845,"kind":"person","name":"WAGENHEIM PHILIP","position":1,"cik":"0001405684","reported_name":"WAGENHEIM PHILIP","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-24T01:23:29.000Z","date":"2026-03-20","kind":"sale","planned":false,"acquired":false,"shares":36800,"price":20.47,"value":753296.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The weighted average sale price for the transaction report was $20.47, and the range of prices were between $20.07 and $20.96, inclusive. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":369347,"source":{"system":"sec-edgar","filing":"0001405684-26-000002","document":"form4-03242026_010325.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000140568426000002/form4-03242026_010325.xml","form_type":"4"}},{"id":834797,"issuer":{"id":5442,"kind":"organization","name":"Swarmer, Inc","symbol":"SWMR"},"owners":[{"id":22845,"kind":"person","name":"WAGENHEIM PHILIP","position":1,"cik":"0001405684","reported_name":"WAGENHEIM PHILIP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A-1 Preferred Stock","published_at":"2026-03-18T23:37:48.000Z","date":"2026-03-18","kind":"exercise","planned":false,"acquired":false,"shares":597980,"ownership":{"direct":false,"nature":"Theseus Capital Partners, LLC"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Series A-1 Preferred Stock converted into shares of common stock on a 1-for-1.8813 basis and had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Series A-1 Preferred Stock converted into shares of common stock on a 1-for-1.8813 basis and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Series A-1 Preferred Stock converted into shares of common stock on a 1-for-1.8813 basis and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Series A-1 Preferred Stock converted into shares of common stock on a 1-for-1.8813 basis and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are directly held by Theseus Capital Partners, LLC (\"Theseus\"). The Reporting Person is the managing partner of Theseus and may be deemed to share voting and dispositive power over the shares held by Theseus."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1124981},"source":{"system":"sec-edgar","filing":"0001104659-26-031469","document":"tm268262-12_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1405684/000110465926031469/tm268262-12_4seq1.xml","form_type":"4"}},{"id":834796,"issuer":{"id":5442,"kind":"organization","name":"Swarmer, Inc","symbol":"SWMR"},"owners":[{"id":22845,"kind":"person","name":"WAGENHEIM PHILIP","position":1,"cik":"0001405684","reported_name":"WAGENHEIM PHILIP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-03-18T23:37:48.000Z","date":"2026-03-18","kind":"exercise","planned":false,"acquired":true,"shares":1124981,"ownership":{"direct":false,"nature":"Theseus Capital Partners, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Series A-1 Preferred Stock converted into shares of common stock on a 1-for-1.8813 basis and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are directly held by Theseus Capital Partners, LLC (\"Theseus\"). The Reporting Person is the managing partner of Theseus and may be deemed to share voting and dispositive power over the shares held by Theseus."}],"balance_after":1124981,"source":{"system":"sec-edgar","filing":"0001104659-26-031469","document":"tm268262-12_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1405684/000110465926031469/tm268262-12_4seq1.xml","form_type":"4"}},{"id":1113264,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":22845,"kind":"person","name":"WAGENHEIM PHILIP","position":1,"cik":"0001405684","reported_name":"WAGENHEIM PHILIP","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2025-06-12T20:55:55.000Z","date":"2025-06-10","kind":"grant","planned":false,"acquired":true,"shares":18864,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in four quarterly installments, commencing from June 10, 2025 until the one-year anniversary thereafter, occurring on the same day of each succeeding fiscal quarter, subject to the Reporting Person's continuous service with the Company on each respective vesting date."}],"balance_after":18864,"derivative":{"exercise_price":9.57,"expiration_date":"2035-06-09","underlying":"Common Stock","underlying_shares":18864},"source":{"system":"sec-edgar","filing":"0001415889-25-016987","document":"form4-06122025_080651.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000141588925016987/form4-06122025_080651.xml","form_type":"4"}},{"id":1475140,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":22845,"kind":"person","name":"WAGENHEIM PHILIP","position":1,"cik":"0001405684","reported_name":"WAGENHEIM PHILIP","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2024-06-19T00:54:46.000Z","date":"2024-06-13","kind":"grant","planned":false,"acquired":true,"shares":11333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest in 4 quarterly installments, commencing from June 13, 2024 until the one year anniversary thereafter, occurring on the same day of each succeeding fiscal quarter, subject to continued service with the Company on each respective vesting date."}],"balance_after":11333,"derivative":{"exercise_price":16.04,"expiration_date":"2034-06-12","underlying":"Common Stock","underlying_shares":11333},"source":{"system":"sec-edgar","filing":"0001415889-24-017520","document":"form4-06192024_120643.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000141588924017520/form4-06192024_120643.xml","form_type":"4"}},{"id":1858689,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":22845,"kind":"person","name":"WAGENHEIM PHILIP","position":1,"cik":"0001405684","reported_name":"WAGENHEIM PHILIP","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-12T20:48:49.000Z","date":"2023-06-08","kind":"grant","planned":false,"acquired":true,"shares":6500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the options shall vest 25% every quarter after the grant date."}],"balance_after":6500,"derivative":{"exercise_price":4.84,"expiration_date":"2033-06-08","underlying":"Common Stock","underlying_shares":6500},"source":{"system":"sec-edgar","filing":"0001104659-23-070395","document":"tm2318426d2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000110465923070395/tm2318426d2_4seq1.xml","form_type":"4"}},{"id":2053713,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":22845,"kind":"person","name":"WAGENHEIM PHILIP","position":1,"cik":"0001405684","reported_name":"WAGENHEIM PHILIP","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-17T11:30:18.000Z","date":"2023-01-15","kind":"grant","acquired":true,"shares":8750,"price":4,"value":35000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of Common Stock were issued to the Reporting Person pursuant to the Issuer's 2020 Equity Compensation Plan in lieu of the non-employee director board and committee cash retainers of $35,000 in the aggregate owed to the Reporting Person for service on the board of directors in 2022."}],"balance_after":406147,"source":{"system":"sec-edgar","filing":"0001104659-23-004010","document":"tm233517-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000110465923004010/tm233517-4_4seq1.xml","form_type":"4"}},{"id":2225338,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":22845,"kind":"person","name":"WAGENHEIM PHILIP","position":1,"cik":"0001405684","reported_name":"WAGENHEIM PHILIP","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-21T22:04:45.000Z","date":"2022-06-16","kind":"grant","acquired":true,"shares":6500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the options shall vest 25% every quarter after the grant date."}],"balance_after":6500,"derivative":{"exercise_price":2.62,"expiration_date":"2032-06-16","underlying":"Common Stock","underlying_shares":6500},"source":{"system":"sec-edgar","filing":"0001104659-22-073099","document":"tm2218674-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000110465922073099/tm2218674-6_4seq1.xml","form_type":"4"}},{"id":2688875,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":22845,"kind":"person","name":"WAGENHEIM PHILIP","position":1,"cik":"0001405684","reported_name":"WAGENHEIM PHILIP","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-02T00:06:55.000Z","date":"2021-05-28","kind":"grant","acquired":true,"shares":3750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest 25% every quarter after the grant date."}],"balance_after":3750,"derivative":{"exercise_price":20.92,"expiration_date":"2031-05-28","underlying":"Common stock","underlying_shares":3750},"source":{"system":"sec-edgar","filing":"0001104659-21-075265","document":"tm2118079-9_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000110465921075265/tm2118079-9_4seq1.xml","form_type":"4"}},{"id":2695074,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":22845,"kind":"person","name":"WAGENHEIM PHILIP","position":1,"cik":"0001405684","reported_name":"WAGENHEIM PHILIP","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-27T01:29:41.000Z","date":"2021-05-24","kind":"purchase","acquired":true,"shares":13500,"price":18.35,"value":247725.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price represents the weighted average purchase price for multiple transactions reported on this line. The prices of the transactions ranged from $18.15 to $18.40, inclusive. Upon request of the SEC staff or the issuer, the reporting person will provide full information regarding the number of shares purchased at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Does not include (i) 166,666 shares previously reported as indirectly held by the reporting person because the reporting person is no longer trustee of the Rapoport Family Trust and (ii) 443,743 shares previously reported as held indirectly through BCM Advisory Partners LLC (the \"LLC\") in which the reporting person did not have a pecuniary interest and which were distributed to other members of the LLC."}],"balance_after":397397,"source":{"system":"sec-edgar","filing":"0001104659-21-072619","document":"tm2117684-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000110465921072619/tm2117684-3_4seq1.xml","form_type":"4"}},{"id":2991037,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":22845,"kind":"person","name":"WAGENHEIM PHILIP","position":1,"cik":"0001405684","reported_name":"WAGENHEIM PHILIP","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)(1)","published_at":"2020-11-06T01:17:47.000Z","date":"2020-11-03","kind":"grant","acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-twelfth (1/12th) of the shares subject to the option shall vest on February 3, 2021, and one-twelfth (1/12th) of the remaining shares subject to the option shall vest every three months thereafter."}],"balance_after":7500,"derivative":{"exercise_price":11.38,"expiration_date":"2030-11-03","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001104659-20-122035","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000110465920122035/a4.xml","form_type":"4"}}]}